Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

ClinicalTrials.gov ID: NCT06851559

Public ClinicalTrials.gov record NCT06851559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Multi-Center Study in Adult Subjects With Eosinophilic Esophagitis (EoE) to Evaluate the Safety and Efficacy of Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate the Safety and Efficacy of Vonoprazan 20 mg Up to 24 Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the efficacy of vonoprazan 20 mg once daily (QD) compared to placebo QD in the number of participants with a peak eosinophilic histologic response \<15 eosinophils per high-power field (eos/hpf) after 12 weeks of therapy.

Study identification

NCT ID
NCT06851559
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Phathom Pharmaceuticals, Inc.
Industry
Enrollment
95 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2025 (Actual)
Primary completion
Sep 11, 2026 (Actual)
Completion
Dec 2026 (Estimated)
Last update posted
Oct 13, 2026

2025 – 2026

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Preferred Research Partners, Inc Little Rock Arkansas 72211 —
GW Research, Inc Chula Vista California 91910 —
Southern California Research Institute Medical Group Los Angeles California 90045 —
Rocky Mountain Gastroenterology Lakewood Colorado 80228 —
Western States Clinical Research, Inc. Wheat Ridge Colorado 80033 —
Connecticut Clinical Research Institute Bristol Connecticut 06010 —
Nature Coast Clinical Research Inverness Florida 34452 —
Encore Borland-Groover Clinical Research Jacksonville Florida 32256 —
International Center for Research Tampa Florida 33614 —
Gastroenterology Associates of Central Georgia, LLC Macon Georgia 31201 —
Treasure Valley Medical Research Boise Idaho 83706 —
Grand Teton Research Group Idaho Falls Idaho 83404 —
Northwestern Medicine Digestive Health Center Chicago Illinois 60611 —
GI Alliance - Gurnee Gurnee Illinois 60031 —
Combined Gastro, LLC Lafayette Louisiana 70503 —
Tandem Clinical Research GI, LLC Marrero Louisiana 70072 —
Woodholme Gastroenterology Associates Glen Burnie Maryland 21061 —
Boston Specialists Boston Massachusetts 02111 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Huron Gastroenterology Associates Ypsilanti Michigan 48197 —
Advanced Research Institute Reno Nevada 89511 —
Weill Cornell Medicine, New York Presbyterian Hospital New York New York 10065 —
UNC Clinical & Translational Research Center Chapel Hill North Carolina 27514 —
GCGA Physicians, LLC dba/Gastro Health Research Cincinnati Ohio 45219 —
Great Lakes Gastroenterology Research LLC Mentor Ohio 44060 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Galen Medical Group - Galen Digestive Health Chattanooga Tennessee 37404 —
Quality Medical Research Nashville Tennessee 37211 —
GI Alliance Cedar Park Texas 78613 —
The Hospitals of Providence Memorial Campus El Paso Texas 79902 —
Texas Digestive Specialists Harlingen Texas 78550 —
Houston Endoscopy and Research Center Houston Texas 77079 —
Research Physicians Network, LLC Houston Texas 77089 —
Biopharma Informatic, LLC McAllen Texas 78503 —
Pearland Physicians Pearland Texas 77581 —
Gastroenterology Research of San Antonio San Antonio Texas 78229 —
Texas Gastro Consultants Tomball Texas 73375 —
Care Access - Ogdon Ogden Utah 84403 —
Advanced Research Institute Ogden Utah 84405 —
Advanced Research Institute Sandy City Utah 84070 —
Blue Ridge Medical Research Lynchburg Virginia 25402 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06851559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06851559 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →